RE: Info28 Aug 2021 11:54
PRO finished, discussions ongoing with FDA, protocol power size calculated (given magnitude of effect, other phase III studies and real world experience doesn’t have to be large) sites identified, drug supply available, data now in Hispanics and African Americans, market size analysis and price point sensitivity re-done by top tier US marketing organisation, licensing partners have access to data room and have been updated.
With respect to 90s thinking, Pfizer Board just about fired me as total ED market ever was going to be $100mill. Definitely more than this in PE but not Viagra at $3.3billion pa. I was also developing Cardura for BPH although HQ felt there wasn’t such a condition. Only did $1.5 bill pay for 9 years,.
His comments seem like someone who knows the facts, from a good basic training but decides to twist them…….hallmarks of an employee “who has been let go” ? Could be licensor trying to knock the price down (joke).
Who is right or wrong will play out over the next 12-18 months. As I’m sure you appreciate as the information could be price sensitive I can only expand slightly beyond what is on the website. On that basis, until we are over the goal line I can’t answer and more bb questions……apologise to the guys please but at this stage lots of interested parties are trying to get information.